Elevated aldosterone and insulin both increase glucocorticoid kinase-1 (SGK-1) activity, which promotes hypertension, IR, and obesity, increasing the risk of CVD (35). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.